Cargando…

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine

Nitroreductases (NRs) are bacterial enzymes that reduce nitro-containing compounds. We have previously reported that NR of intestinal bacteria is a key factor promoting berberine (BBR) intestinal absorption. We show here that feeding hamsters with high fat diet (HFD) caused an increase in blood lipi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Tong, Qian, Shou, Jia-Wen, Zhao, Zhen-Xiong, Li, Xiao-Yang, Zhang, Xian-Feng, Ma, Shu-Rong, He, Chi-Yu, Lin, Yuan, Wen, Bao-Ying, Guo, Fang, Fu, Jie, Jiang, Jian-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525748/ https://www.ncbi.nlm.nih.gov/pubmed/28744326 http://dx.doi.org/10.7150/thno.18290

Ejemplares similares

Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015)

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
por: Wang, Yan, et al.
Publicado: (2021)

Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
por: Jia, Xiaokang, et al.
Publicado: (2021)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
por: Ma, Shu-Rong, et al.
Publicado: (2022)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2021)

Berberine influences multiple diseases by modifying gut microbiota
por: Yang, Fujie, et al.
Publicado: (2023)

Phytosterols Alleviate Hyperlipidemia by Regulating Gut Microbiota and Cholesterol Metabolism in Mice
por: Lv, Wei-Jie, et al.
Publicado: (2023)

In Vitro Study of the Metabolic Characteristics of Eight Isoquinoline Alkaloids from Natural Plants in Rat Gut Microbiota
por: He, Chi-Yu, et al.
Publicado: (2017)

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
por: Cheng, Hao, et al.
Publicado: (2022)

Alterations of Gut Microbiota and Blood Lipidome in Gestational Diabetes Mellitus With Hyperlipidemia
por: Liu, He, et al.
Publicado: (2019)

Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
por: Li, Xiao-Yang, et al.
Publicado: (2015)

Modulating gut microbiota as an anti-diabetic mechanism of berberine
por: Han, Junling, et al.
Publicado: (2011)

Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review
por: Koppen, Laura M., et al.
Publicado: (2017)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
por: Di Bisceglie, Adrian M., et al.
Publicado: (2020)

Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats
por: Zhao, Jin-Dong, et al.
Publicado: (2021)

Berberine mitigates intracerebral hemorrhage-induced neuroinflammation in a gut microbiota-dependent manner in mice
por: Liu, Jing, et al.
Publicado: (2023)

Transplantation of Gut Microbiota From High-Fat-Diet-Tolerant Cynomolgus Monkeys Alleviates Hyperlipidemia and Hepatic Steatosis in Rats
por: Gao, Jiang-Mei, et al.
Publicado: (2022)

Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice
por: Li, Cai‐Na, et al.
Publicado: (2019)

Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
por: Chen, Yuting, et al.
Publicado: (2022)

The Effects of Berberine on the Gut Microbiota in Apc (min/+) Mice Fed with a High Fat Diet
por: Wang, Huan, et al.
Publicado: (2018)

Study on the protective effect of berberine treatment on sepsis based on gut microbiota and metabolomic analysis
por: Pan, Huibin, et al.
Publicado: (2022)

Berberine displays antitumor activity in esophageal cancer cells in vitro
por: Jiang, Shu-Xian, et al.
Publicado: (2017)

The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
por: Chang, Xin-xia, et al.
Publicado: (2012)

Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese
por: Alolga, Raphael N., et al.
Publicado: (2016)

Effects of Berberine on the Gastrointestinal Microbiota
por: Zhang, Lichao, et al.
Publicado: (2021)

Gut microbiota signature as predictors of adverse outcomes after acute ischemic stroke in patients with hyperlipidemia
por: Chen, Jiaxin, et al.
Publicado: (2022)

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
por: Kim, Jiyeon, et al.
Publicado: (2019)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds
por: Li, Meng, et al.
Publicado: (2016)

Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
por: Tan, Xiang-Shan, et al.
Publicado: (2013)

Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine
por: Xu, Xizhan, et al.
Publicado: (2020)

Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
por: Pan, Libin, et al.
Publicado: (2023)

Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice
por: Shi, Ying, et al.
Publicado: (2021)

Dose-response effect of berberine on bile acid profile and gut microbiota in mice
por: Guo, Ying, et al.
Publicado: (2016)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms
por: Shou, Jia-Wen, et al.
Publicado: (2022)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production
por: Huang, Chao, et al.
Publicado: (2022)

Berberine Reduces Lipid Accumulation in Obesity via Mediating Transcriptional Function of PPARδ
por: Shou, Jia-Wen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4jkmkspeuqot0ip83d1e5sl67v